Keeps Biopharma Inc. (KOSDAQ:256940)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,460.00
-130.00 (-1.51%)
At close: Apr 17, 2026

Keeps Biopharma Revenue

In the year 2025, Keeps Biopharma had annual revenue of 170.15B KRW with 33.36% growth. Keeps Biopharma had revenue of 45.23B in the quarter ending December 31, 2025, with 37.74% growth.

Revenue
170.15B
Revenue Growth
+33.36%
P/S Ratio
1.00
Revenue / Employee
1.56B
Employees
109
Market Cap
169.86B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025170.15B42.56B33.36%
Dec 31, 2024127.58B35.45B38.48%
Dec 31, 202392.13B77.52B530.30%
Dec 31, 202214.62B10.36B243.08%
Dec 31, 20214.26B-10.96B-72.00%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Avaco392.90B
C&G Hi Tech196.19B
Osung Advanced Materials165.71B
DMS Co.,Ltd.155.47B
DEVICE CO.,Ltd84.08B
GIS Co., Ltd.75.81B
FNS TECH.73.66B
HB SOLUTION62.85B
Revenue Rankings